Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1966-12-26
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0029-7844
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
309-14
|
pubmed:dateRevised |
2009-10-26
|
pubmed:meshHeading |
pubmed-meshheading:4162030-Adenocarcinoma,
pubmed-meshheading:4162030-Adenocarcinoma, Papillary,
pubmed-meshheading:4162030-Female,
pubmed-meshheading:4162030-Humans,
pubmed-meshheading:4162030-Hydroxyprogesterones,
pubmed-meshheading:4162030-Palliative Care,
pubmed-meshheading:4162030-Uterine Cervical Neoplasms,
pubmed-meshheading:4162030-Uterine Neoplasms
|
pubmed:year |
1966
|
pubmed:articleTitle |
Progesterone caproate in the treatment of endometrial cancer.
|
pubmed:publicationType |
Journal Article
|